107 related articles for article (PubMed ID: 5510354)
1. [Antiangina medications].
Reuse J
Brux Med; 1970 Sep; 50(9):553-5. PubMed ID: 5510354
[No Abstract] [Full Text] [Related]
2. [Pharmacologic bases of antiangina properties of amiodarone].
Charlier R
Brux Med; 1970 Sep; 50(9):651-6. PubMed ID: 5510367
[No Abstract] [Full Text] [Related]
3. [Nitroglycerin and slow-acting drugs in angina pectoris].
Oye I
Tidsskr Nor Laegeforen; 1972 Feb; 92(5):353-5. PubMed ID: 4622663
[No Abstract] [Full Text] [Related]
4. Management of angina: long-acting coronary vasodilators.
Joines IW
J Med Assoc Ga; 1973 Feb; 62(2):54-5. PubMed ID: 4687170
[No Abstract] [Full Text] [Related]
5. [Coronary artery-dilating agents].
Ignat'ev MV
Feldsher Akush; 1989 Jan; 54(1):40-4. PubMed ID: 2703077
[No Abstract] [Full Text] [Related]
6. [Verapamil in the treatment of angina pectoris].
Sandler G
Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1323+. PubMed ID: 4991636
[No Abstract] [Full Text] [Related]
7. [Clinical evaluation of coronary dilators].
Kreuzer H
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):186-94. PubMed ID: 4896197
[No Abstract] [Full Text] [Related]
8. Nitrate tolerance--from mechanism to prevention.
Gambhir DS; Sudha R; Gambhir JK
Indian Heart J; 1997; 49(5):487-8. PubMed ID: 9505013
[No Abstract] [Full Text] [Related]
9. Vanidil: a newly synthesized antiangina nonvolatile organic solid nitrate.
Chen IJ; Liu ZI; Yeh JL; Wu BN
Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Sep; 7(9):476-80. PubMed ID: 1819275
[TBL] [Abstract][Full Text] [Related]
10. Failure of "intensain" to improve exercise tolerance in patients with angina pectoris.
Conway N; Gupta GD; Sowton E
Acta Cardiol; 1968; 23(5):434-8. PubMed ID: 4886340
[No Abstract] [Full Text] [Related]
11. [Ethical problems in antiangina drug experimentation].
Vastesaerger M
Brux Med; 1970 Sep; 50(9):675-6. PubMed ID: 4928627
[No Abstract] [Full Text] [Related]
12. [Methods of experimental study of drugs for angina pectoris].
Duchene-Marullaz P
Therapie; 1970; 25(5):863-91. PubMed ID: 4922244
[No Abstract] [Full Text] [Related]
13. The pharmacological basis of antianginal drugs.
Melville KI
Pharmacol Physicians; 1970 Mar; 4(3):1-8. PubMed ID: 4985076
[No Abstract] [Full Text] [Related]
14. [Pharmacology and clinical effects of lidoflazine].
Janssen PA
Actual Pharmacol (Paris); 1970; 23():135-61. PubMed ID: 4948983
[No Abstract] [Full Text] [Related]
15. [Therapy of angina pectoris, with reference to coronary vasodilators].
Niitani H
Naika; 1967 Jun; 19(6):1079-85. PubMed ID: 4865499
[No Abstract] [Full Text] [Related]
16. Coronary vasoconstriction: where do we stand in 1999. An important, multifaceted but elusive role.
Maseri A; Crea F; Lanza GA
Cardiologia; 1999 Feb; 44(2):115-8. PubMed ID: 10208047
[No Abstract] [Full Text] [Related]
17. [The coronary dilatator effect of various reference drugs].
Duchene-Marullaz P; Cosnier D; Grimald J
Therapie; 1969; 24(4):617-20. PubMed ID: 5821999
[No Abstract] [Full Text] [Related]
18. [Drug information. Therapeutic main group: agents for the treatment of angina pectoris. 10th and last part. 4. Other angina pectoris agents].
Lumholtz IB
Sygeplejersken; 1980 May; 80(20):23. PubMed ID: 6902553
[No Abstract] [Full Text] [Related]
19. [On the treatment of stenocardia pains following heart infarct].
Wolkerstorfer H
Wien Klin Wochenschr; 1965 Dec; 77(51):1012-4. PubMed ID: 5331454
[No Abstract] [Full Text] [Related]
20. [Our experiences with a new coronary vasodilator (Rigedal)].
Udvarhelyi A
Orv Hetil; 1966 Jul; 107(31):1470-1. PubMed ID: 5943635
[No Abstract] [Full Text] [Related]
[Next] [New Search]
